AAN MEETING: Study Shows Migraine And Depression May Be Treated Together
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




AAN MEETING: Study Shows Migraine And Depression May Be Treated Together

MINNEAPOLIS, MN -- April 30, 1998 -- Migraine and depression, two commonly linked conditions, may now be treated together, according to results of a new study presented today at the 50th annual meeting of the American Academy of Neurology.

The study showed that Zeneca Pharmaceuticals’ oral medication for the treatment of acute migraine Zomig(TM) (zolmitriptan), is safe when taken with the antidepression treatment fluoxetine, commonly known by its trade name Prozac. Other migraine therapies, including sumatriptan, have been shown to interact with fluoxetine.

An estimated 25 to 30 million people suffer from migraine in the United States. Studies of migraine and depression show consistent evidence of a substantial association between these two conditions because of their common link -- serotonin. With the onset of a migraine attack, serotonin activity in the brain changes dramatically. Changes in serotonin activity within the brain also are thought to be involved in depression.

"Given that depression and migraine often occur together, it is likely that some patients may take Zomig and an antidepressant at the same time," said Gerardo Torres, M.D., US Project Physician for Zomig. "Our research suggests migraine patients who suffer from depression may treat both diseases safely with this combination of drugs."

The objective of the study was to investigate the effect of multiple doses of fluoxetine on the blood levels and safety profile of Zomig. In this randomised, double-blind, two-period crossover study, 20 healthy male and female volunteers received fluoxetine or placebo daily for 28 days. With the last dose of fluoxetine or placebo, subjects took a single oral dose of Zomig in the fasting state.

Results of the study show fluoxetine has no effects on the blood levels of Zomig or its metabolites. Zomig was well tolerated when given alone or with fluoxetine. There was a small clinically insignificant increase in blood pressure following Zomig, which was unaltered by fluoxetine.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities